ViroPharma Inc. Message Board
-
240 million in cash / 22.7 m shares =
$10.57 a share. This stock is WAY OVERSOLD. The smart buyers will be coming out like wolves soon. Very Strong Buy in my opinion.
-
Minor oversight, I'm sure! What about their 180 million in notes due in 2007. That leaves 60 million now, and burning how fast! Anyway, using your math now divide 60 million by 22.7 m shares = less then $3.00 per share! Getting close, should be there in 3 or 4 more days!
- 1 Reply to daylatedollarshorter
-
Your minor oversight. If they have
240 million they will invest in into
either a bank account that pays interest
or some kind of interest baring investment.
The 180 million in notes due are 5 years
away and in the mean time their interest
will add to several millions more plus
any drug they may come up with between
now and 5 years from now.
They have plenty of cash for the next
several years...and if they can fix the
common cold drug to become approve
they will be fixed for life. There is
always a chance VPHM can partner with
another company on future new drugs..
Minor oversight, I'm sure! What about their 180 million in notes due in 2007. That leaves 60 million now, and burning how fast! Anyway, using your math now divide 60 million by 22.7 m shares = less then $3.00 per share! Getting close, should be there in 3 or 4 more days!
-
It makes no difference one way or another. VPHM WILL burn/blow out all the cash before it folds. You should find out where the money came from since VPHM never had anything on the market.
The moral of the story: If VPHM doesn't have anything approved by the FDA soon, the share price will drop to two cents.
Just my 2 cents
Kevin -
Yea, Your not kidding. Especially when Viropharma comes out with the revised studies for Picovir in the second quarter. We should see a nice rise in share price. If not before then. We will get a huge lift if the panel gets the information it's looking for.
-